The Signal Directory

HealthTech executives worth following

Founders, investors, health system and payer leaders, policy people and analysts. Filter by the part of the industry they work in and where they post.

Looking for practising clinicians instead? Open the clinician directory.

Alex Zhavoronkov, PhD

Founder and Co-CEO, Insilico Medicine

Pharma & Life Sciences

Provides regular updates on the application of generative AI to chemistry and biology, clinical trial milestones, and longevity research.

Generative AI / Longevity Research / Drug Discovery

Best for: AI engineers, medicinal chemists, and biotech entrepreneurs

Andrew Hopkins, PhD

Founder and CEO, Exscientia

Pharma & Life Sciences

Offers visionary leadership perspectives on automated drug design, automated chemistry, and using patient-tissue-led platforms for oncology clinical trials.

AI Drug Design / Precision Oncology / Automated Chemistry

Best for: Computational chemists and precision medicine advocates

Brad Loncar

CEO, Loncar Investments

Pharma & Life Sciences

Offers real-time commentary on biotechnology stock markets, clinical trial readouts, and global pharmaceutical industry trends, including a strong focus on Chinese biotech.

Biotech Investing / Cancer Immunotherapy / Global Pharma

Best for: Public market biotech investors and industry analysts

Bruce Booth, PhD

Partner, Atlas Venture

Pharma & Life Sciences

Offers detailed, data-driven analysis of biotech venture capital trends, early-stage drug development, and the financial ecosystem supporting new therapeutics.

Biotech Investing / Drug Discovery / Venture Capital

Best for: Biotech founders, venture capitalists, and life sciences executives

Craig Lipset, MPH

Founder and Advisor, Clinical Innovation Partners

Pharma & Life Sciences

Delivers deep insights into the modernization of clinical trials, decentralization strategies, digital health tools, and patient advocacy integration in drug development.

Clinical Trials / Decentralized Trials / Patient Centricity

Best for: Clinical trial operations managers and digital health innovators

Daphne Koller, PhD

Founder and CEO, insitro

Pharma & Life Sciences

Explores how advanced machine learning can transform drug discovery and clinical development, sharing key updates on predictive biology and therapeutic design.

Machine Learning / Drug Discovery / Computational Biology

Best for: AI researchers and computer-aided drug discovery specialists

John Maraganore, PhD

Founder and Principal, JMaraganore Consulting

Pharma & Life Sciences

Shares valuable executive-level mentorship, insights on biotech corporate governance, and expert perspectives on the next generation of genomic and molecular therapies.

RNA Interference / Biotech Leadership / Drug Development

Best for: Biotech executives, drug developers, and researchers

Peter Kolchinsky, PhD

Managing Partner, RA Capital Management

Pharma & Life Sciences

Writes extensively on drug pricing policy, patent ecosystems, biotech capital markets, and the societal value of pharmaceutical innovation.

Biotech Policy / Drug Pricing / Venture Capital

Best for: Healthcare policy analysts, biotech executives, and investors

Thomas Clozel, MD

Co-Founder and CEO, Owkin

Pharma & Life Sciences

Discusses how federated learning and artificial intelligence can optimize clinical trials, discover new biomarkers, and advance precision oncology.

AI in Oncology / Precision Medicine / Federated Learning

Best for: Oncologists, data scientists, and pharmaceutical researchers

Showing 9 of 121 people. Listings are editorial, not paid, and nobody pays to appear here.